Cargando…

Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools

Tuberculosis (TB) is one of the emerging infectious diseases in the world. DprE1 (Decaprenylphosphoryl-β-d-ribose 2′-epimerase), an enzyme accountable for mycobacterial cell wall synthesis was the first drug gable target based on discoveries of inhibitors via HTS (high throughput screening). Since t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mali, Suraj N., Pandey, Anima, Bhandare, Richie R., Shaik, Afzal B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525719/ https://www.ncbi.nlm.nih.gov/pubmed/36180452 http://dx.doi.org/10.1038/s41598-022-20325-1

Ejemplares similares

Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
por: Wang, Pengxu, et al.
Publicado: (2021)

Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
por: Yadav, Veena D., et al.
Publicado: (2023)

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
por: Chhabra, Sonali, et al.
Publicado: (2021)

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023)

Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase
por: Oh, Sangmi, et al.
Publicado: (2018)

Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014)

Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
por: Batt, Sarah M., et al.
Publicado: (2023)

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Decaprenylphosphoryl-β-D-Ribose 2′-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis
por: Crellin, Paul K., et al.
Publicado: (2011)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2018)

Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach
por: Daoui, Ossama, et al.
Publicado: (2023)

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
por: Ramey, Michelle E., et al.
Publicado: (2023)

Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
por: Robertson, Gregory T., et al.
Publicado: (2021)

QSAR and Molecular Docking Studies of Pyrimidine-Coumarin-Triazole Conjugates as Prospective Anti-Breast Cancer Agents
por: Subramani, Arun Kumar, et al.
Publicado: (2022)

Thiazole–Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation
por: Kasetti, Ashok Babu, et al.
Publicado: (2021)

DER NEWSLETTER DES DPR
Publicado: (2022)

Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives
por: Shaik, Afzal, et al.
Publicado: (2020)

Ion Transport Modulators as Antimycobacterial Agents
por: Mitini-Nkhoma, Steven C., et al.
Publicado: (2020)

Therapeutic Potential of Curcumin as an Antimycobacterial Agent
por: Barua, Nilakshi, et al.
Publicado: (2021)

Discovery of quinolone derivatives as antimycobacterial agents
por: Liu, Kun-Lin, et al.
Publicado: (2021)

Synthesis and Activity of Novel Acylthiourea with Hydantoin
por: Han, Jintao, et al.
Publicado: (2013)

Phase-Transfer-Catalyzed Alkylation of Hydantoins
por: Keenan, Thomas, et al.
Publicado: (2022)

Design, Synthesis, and Antibacterial and Antifungal Activities of Novel Trifluoromethyl and Trifluoromethoxy Substituted Chalcone Derivatives
por: Lagu, Surendra Babu, et al.
Publicado: (2020)

Study on the Formation of Glycine by Hydantoin and Its Kinetics
por: Zhao, Hangyu, et al.
Publicado: (2020)

Biologically Oriented Hybrids of Indole and Hydantoin Derivatives
por: Kochetkov, Konstantin A., et al.
Publicado: (2023)

Resolution enhancement with deblurring by pixel reassignment (DPR)
por: Zhao, Bingying, et al.
Publicado: (2023)

2-Amino Thiazole Derivatives as Prospective Aurora Kinase Inhibitors against Breast Cancer: QSAR, ADMET Prediction, Molecular Docking, and Molecular Dynamic Simulation Studies
por: Bathula, Sivakumar, et al.
Publicado: (2023)

Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents
por: Krátký, Martin, et al.
Publicado: (2017)

The Bucherer–Bergs Multicomponent Synthesis of Hydantoins—Excellence in Simplicity
por: Kalník, Martin, et al.
Publicado: (2021)

Mechanochemical Preparation of Protein : hydantoin Hybrids and Their Release Properties
por: Yuan, Yusheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pva3e4igr74m254c3queqj4m6l